Expected clinical package for OTL-200 BLA for MLD using data from existing patients clarified with FDA
Guidance obtained on design of OTL-203 global registrational trial for MPS-IH
Enrollment goal met in OTL-201 POC trial for MPS-IIIA
Updates for OTL-103 MAA and BLA submission timelines for WAS
Company to host conference call today at 8:00 a.m. ET
Conference Call Information
Orchard will host a conference call today at 8:00 a.m. ET to discuss recent regulatory and clinical updates for its lead programs. The conference call will be broadcast live in listen-only mode under "News & Events" in the “Investors & Media” section of the company's website at www.orchard-tx.com, and a replay will be archived on the Orchard website following the presentation. To ask a question, please dial (866) 987-6504 (U.S. domestic) or +1 (602) 563-8620 (international) and refer to conference ID 2856986. Please dial in at least 10 minutes in advance to ensure a timely connection to the call.
https://finance.yahoo.com/news/orchard-therapeutics-announces-regulatory-clinical-110000045.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.